Nutritional aspects of liver disease and transplantation

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 4, Issue 6, 2001, Pages 581-589

  Cabré, Eduard ^a   Gassull, Miquel A ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN;

ALCOHOL LIVER DISEASE; ALCOHOLISM; BIOENERGY; ENTERIC FEEDING; HUMAN; IMPEDANCE; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALNUTRITION; OBESITY; PARENTERAL NUTRITION; PATHOGENESIS; REVIEW;

DEFICIENCY DISEASES; HUMANS; LIVER CIRRHOSIS; LIVER DISEASES; LIVER TRANSPLANTATION; MICRONUTRIENTS; NUTRITION DISORDERS; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT;

EID: 0035744447     PISSN: 13631950     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075197-200111000-00020     Document Type: Review

References (66)

1. Bioelectric impedance analysis: Experience with male patients with cirrhosis
2. Whole-body and segmental bioelectrical impedance analysis in patients with cirrhosis of the liver: Changes after treatment of ascites
3. A comparison of skinfold anthropometry and bioelectrical impedance analysis for measuring percentage body fat in patients with cirrhosis
4. Fiabilidad del análisis de impedancia bioeléctrica como método de monitorización nutricional en la cirrosis con ascitis
5. Bioelectrical impedance analysis is a useful bedside technique to assess malnutrition in cirrhotic patients with and without ascites
6. Utility of standard nutritional parameters in detecting body cell mass depletion in patients with end-stage liver disease
7. A comparison of skinfold anthropometry and dual-energy X-ray absorptiometry for the evaluation of body fat in cirrhotic patients
8. Assessment of body composition using dual energy X-ray absorptiometry in patients with liver cirrhosis: Comparison with anthropometry
9. Decreased muscle strength in patients with alcoholic liver cirrhosis in relation to nutritional status, alcohol abstinence, liver function, and neuropathy
10. Nutritional aspects of chronic liver disease
11. Nature and quantity of fuels consumed in patients with alcoholic cirrhosis
12. Energy expenditure and substrate oxidation in patients with cirrhosis: The impact of cause, clinical staging and nutritional state
13. Energy and substrate metabolism in patients with cirrhosis
14. Glucose and insulin metabolism in cirrhosis
15. Substrate oxidation in patients with cirrhosis: Comparison with other nutritional markers
16. Serum leptin concentration in moderate and severe obesity: Relationship with clinical, anthropometric and metabolic factors
17. Leptin
18. Leptin: Fundamental aspects
19. Increased circulating leptin levels in chronic alcoholism
20. Gender-dependent alterations in serum leptin in alcoholic cirrhosis
21. Increased circulating leptin in alcoholic cirrhosis: Relation to release and disposal
22. Serum leptin levels in patients with viral chronic hepatitis or liver cirrhosis
23. Serum leptin levels in post-hepatitis liver cirrhosis
24. Elevated bound leptin correlates with energy expenditure in cirrhotics
25. Trace metals in liver disease
26. Lipoperoxidation, trace elements and vitamin E in patients with liver cirrhosis
27. Overt hepatic encephalopathy precipitated by zinc deficiency
28. Oral zinc supplementation improves hepatic encephalopathy. Results of a randomized controlled trial
29. Short-term oral zinc supplementation does not improve chronic hepatic encephalopathy. Results of a double-blind crossover trial
30. A review of epidemiologic evidence that carotenoids reduce the risk of cancer
31. Low serum retinol levels are associated with hepatocellular carcinoma in patients with chronic liver disease
32. Decreased serum levels of beta-carotene in patients with hepatocellular carcinoma
33. Parenteral nutrition with branched-chain amino acids in hepatic encephalopathy. A meta-analysis
34. Amino acid therapy of alcoholic hepatitis
35. Effect of parenteral amino acid supplementation in alcoholic hepatitis
36. A prospective randomized clinical trial of peripheral amino acid-glucose supplementation in acute alcoholic hepatitis
37. A randomized controlled study of peripheral parenteral nutrition in moderate and severe alcoholic hepatitis
38. Effect of parenteral amino acid supplementation on short-term and long-term outcomes in severe alcoholic hepatitis: A randomized controlled trial
39. Enteral nutrition in malnourished patients with hepatic cirrhosis and acute hepatic encephalopathy
40. Effect of total enteral nutrition on the short-term outcome of severely malnourished cirrhotics: A randomized controlled trial
41. Early feeding or enteral nutrition in patients with cirrhosis after bleeding from esophageal varices? A randomized controlled study
42. Nutritional support in liver disease
43. Post-feeding hyperammonaemia in patients with transjugular intrahepatic portosystemic shunt and liver cirrhosis: Role of small intestinal ammonia release and route of nutrient administration
44. The role of the small intestine in ammonia production after gastric blood administration
45. Porcine intestinal ammonia liberation. Influence of food intake, lactulose and neomycin treatment
46. Lactulose or paromomycin do not affect ammonia generation in the isolated perfused rat small intestine
47. A randomized clinical trial of supplementary parenteral nutrition in jaundiced alcoholic cirrhotic patients
48. ESPEN guidelines for nutrition in liver disease and transplantation
49. VA cooperative study on alcoholic hepatitis. III: Changes in protein-calorie malnutrition associated with 30 days of hospitalization with and without enteral nutritional therapy
50. Accelerated improvement of alcoholic liver disease with enteral nutrition
51. Nutrition in chronic liver disease and liver transplantation
52. Do corticosteroids reduce mortality from alcoholic hepatitis? A meta-analysis of the randomized trials
53. Glucocorticoids are ineffective in alcoholic hepatitis: A meta-analysis adjusting for confounding variables
54. Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition. A multicenter randomized trial
55. Influence of selected patient variables and operative blood loss on six-month survival following liver transplantation
56. Identification of high- and low-risk patients before liver transplantation. A prospective cohort study of nutritional and metabolic parameters in 150 patients
57. Lack of relationship between preoperative measures of the severity of cirrhosis and short-term survival after liver transplantation
58. Energy storage and cytokine response in patients undergoing liver transplantation
59. Impact of nutritional status on outcomes after liver transplantation
60. A prospective randomized study of preoperative nutritional supplementation in patients awaiting elective orthotopic liver transplantation
61. Liver transplantation in patients with severe obesity
62. Liver transplantation in the morbidly obese
63. Increased early morbidity and mortality with acceptable long-term function in severely obese patients undergoing liver transplantation
64. Postoperative morbidity, mortality, costs, and long-term survival in severely obese patients undergoing orthotopic liver transplantation
65. Nutritional issues in cirrhosis and liver transplantation
66. Nutritional and metabolic issues in cirrhosis and liver transplantation